Hot Investor Mandate: USA-Based Private Investment Firm Seeks Venture and Growth-Stage Opportunities in Clinical Stage and Close to Commercialization

19 May

A private investment firm in the USA focuses on investments in the healthcare industry. The investment size can vary greatly and is very flexible depending on each company’s needs.  The firm provides venture capital and growth capital to healthcare companies. For early-stage investments, the firm targets companies that provide solutions for hospital acquired infections, medication errors, healthcare system operational efficiency enhancements and cost reductions, and chronic disease management, and it typically invests equity or convertible preferred equity in post series A rounds. For growth investments, the firm targets companies with compelling products and strong position in niche markets and with an EBITDA in excess of $2 million. The firm primarily invests in companies based in US.

The firm will consider investments in therapeutics and medical devices, as well as healthcare IT and services. The firm will not consider companies in pre-clinical stage, and typically invests in companies that are near commercialization and commercialization stage.

The firm focuses on private companies with strong and experienced management team. The firm usually takes a board seat post investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: